These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35057695)

  • 21. European Reference Networks and Guideline Development and Use: Challenges and Opportunities.
    Morciano C; Laricchiuta P; Taruscio D; Schünemann H
    Public Health Genomics; 2015; 18(5):318-20. PubMed ID: 26227062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. European Reference networks for rare diseases: what is the conceptual framework?
    Héon-Klin V
    Orphanet J Rare Dis; 2017 Aug; 12(1):137. PubMed ID: 28784158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study.
    Sloan M; Wincup C; Harwood R; Pollak TA; Massou E; Bosley M; Pitkanen M; Zandi MS; Leschziner G; Barrere C; Ubhi M; Andreoli L; Brimicombe J; Diment W; Jayne D; Gordon C; Naughton F; D'Cruz D
    Rheumatology (Oxford); 2024 May; 63(5):1259-1272. PubMed ID: 37491699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards European harmonisation of healthcare for patients with rare immune disorders: outcome from the ERN RITA registries survey.
    Papa R; Cant A; Klein C; Little MA; Wulffraat NM; Gattorno M; Ruperto N;
    Orphanet J Rare Dis; 2020 Jan; 15(1):33. PubMed ID: 32000824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical aspects of autoimmune rheumatic diseases.
    Goldblatt F; O'Neill SG
    Lancet; 2013 Aug; 382(9894):797-808. PubMed ID: 23993190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The European Reference Network for Rare Neurological Diseases.
    Reinhard C; Bachoud-Lévi AC; Bäumer T; Bertini E; Brunelle A; Buizer AI; Federico A; Gasser T; Groeschel S; Hermanns S; Klockgether T; Krägeloh-Mann I; Landwehrmeyer GB; Leber I; Macaya A; Mariotti C; Meissner WG; Molnar MJ; Nonnekes J; Ortigoza Escobar JD; Pérez Dueñas B; Renna Linton L; Schöls L; Schuele R; Tijssen MAJ; Vandenberghe R; Volkmer A; Wolf NI; Graessner H
    Front Neurol; 2020; 11():616569. PubMed ID: 33519696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are the European reference networks for rare diseases ready to embrace machine learning? A mixed-methods study.
    Iskrov G; Raycheva R; Kostadinov K; Gillner S; Blankart CR; Gross ES; Gumus G; Mitova E; Stefanov S; Stefanov G; Stefanov R
    Orphanet J Rare Dis; 2024 Jan; 19(1):25. PubMed ID: 38273306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rituximab in systemic autoimmune rheumatic diseases: indications and practical use.
    Berghen N; Vulsteke JB; Westhovens R; Lenaerts J; De Langhe E
    Acta Clin Belg; 2019 Aug; 74(4):272-279. PubMed ID: 30253707
    [No Abstract]   [Full Text] [Related]  

  • 29. Mobile app requirements for patients with rare liver diseases: A single center survey for the ERN RARE-LIVER‬‬‬.
    Rüther DF; Sebode M; Lohse AW; Wernicke S; Böttinger E; Casar C; Braun F; Schramm C
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101760. PubMed ID: 34325014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of EXABO - An Expert Advisory Board for the European Reference Network for Rare Respiratory Diseases.
    Walther D; Steinmann O; Wagner TOF; Storf H
    Stud Health Technol Inform; 2020 Jun; 270():986-990. PubMed ID: 32570529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European expert network on rare communicable diseases and other rare diseases linked to mobility and globalisation focused on health care provision (EURaDMoG): a feasibility study.
    Requena-Méndez A; Bisoffi Z; Vives-Corrons JL; Gascon J; Plasència A
    Orphanet J Rare Dis; 2020 Oct; 15(1):291. PubMed ID: 33066818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER.
    Bernts LHP; Jones DEJ; Kaatee MM; Lohse AW; Schramm C; Sturm E; Drenth JPH
    Orphanet J Rare Dis; 2019 Jul; 14(1):169. PubMed ID: 31287000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A molecular taxonomy for systemic autoimmune rheumatic diseases (SARDs): learning lessons from oncology?
    Reynolds JA; Bruce IN
    Rheumatology (Oxford); 2020 Sep; 59(9):2193-2194. PubMed ID: 32182369
    [No Abstract]   [Full Text] [Related]  

  • 35. Bridging the Gap between Health and Social Care for Rare Diseases: Key Issues and Innovative Solutions.
    Castro R; Senecat J; de Chalendar M; Vajda I; Dan D; Boncz B;
    Adv Exp Med Biol; 2017; 1031():605-627. PubMed ID: 29214594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards FAIRification of sensitive and fragmented rare disease patient data: challenges and solutions in European reference network registries.
    Dos Santos Vieira B; Bernabé CH; Zhang S; Abaza H; Benis N; Cámara A; Cornet R; Le Cornec CMA; 't Hoen PAC; Schaefer F; van der Velde KJ; Swertz MA; Wilkinson MD; Jacobsen A; Roos M
    Orphanet J Rare Dis; 2022 Dec; 17(1):436. PubMed ID: 36517834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer Risk in Patients With Inflammatory Systemic Autoimmune Rheumatic Diseases: A Nationwide Population-Based Dynamic Cohort Study in Taiwan.
    Yu KH; Kuo CF; Huang LH; Huang WK; See LC
    Medicine (Baltimore); 2016 May; 95(18):e3540. PubMed ID: 27149461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparisons of neutrophil-, monocyte-, eosinophil-, and basophil- lymphocyte ratios among various systemic autoimmune rheumatic diseases.
    Yang Z; Zhang Z; Lin F; Ren Y; Liu D; Zhong R; Liang Y
    APMIS; 2017 Oct; 125(10):863-871. PubMed ID: 28766758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interoperability Architecture for a Paediatric Oncology European Reference Network.
    Nitzlnader M; Canete Nieto A; Ribelles AJ; Brunmair B; Ladenstein R; Schreier G
    Stud Health Technol Inform; 2016; 223():39-45. PubMed ID: 27139383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Networking in rare cancers: What was done, what's next.
    Frezza AM; Trama A; Blay JY; Casali PG
    Eur J Surg Oncol; 2019 Jan; 45(1):16-18. PubMed ID: 29685758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.